Novocure has obtained CE Mark approval for its Optune Lua device to treat adults with metastatic non-small cell lung cancer ...

Vivasure hope to find room in a competitive market with its surtureless implant that is absorbed 180 days after vessel ...

Biolinq has secured $100m in Series C funds to support the regulatory approval process in the US to launch its intradermal ...

Until recently, the choice of full-service outsourcing (FSO) vs functional service partnerships (FSP) most frequently was ...

Semiconductors are used in half of all medical devices, with impending tariffs on their import likely to impact the US ...

ARUP Laboratories has introduced a blood test for phosphorylated tau 217 to aid in diagnosing the pathology of Alzheimer's ...

BD has introduced the HemoSphere Alta platform, incorporating predictive algorithms based on AI to manage instability in ...

Leidos has announced a $10m investment to expedite the AI usage in disease detection with the University of Pittsburgh's ...

The United Arab Emirates Ministry (UAE) of Health and Prevention has approved Biomerica's Fortel Kidney Disease Test for sale ...

Zimmer Biomet has completed the previously announced acquisition of Paragon 28 for an enterprise value of approximately ...

NHS surgeons in England will be able to use surgical robotic systems that will improve the care of patients undergoing a ...

Despite major product launches from diabetes rivals last year, Abbott’s diabetes unit brought in $1.8bn total Q1 sales to ...